1025936-09-7 Usage
Description
(4-chlorothiazol-5-yl)methanol is a chemical compound belonging to the class of thiazole compounds. It is a derivative of thiazole with a chloro group and a hydroxymethyl group attached to the 4th and 5th carbon atoms, respectively. (4-chlorothiazol-5-yl)methanol has potential applications in medicinal chemistry, particularly in the development of pharmaceutical drugs. Its chemical structure and properties make it suitable for use as a building block in the synthesis of various biologically active molecules. Additionally, it may also have uses in agrochemicals and material science. Overall, (4-chlorothiazol-5-yl)methanol is a versatile compound with potential applications in various fields.
Uses
Used in Medicinal Chemistry:
(4-chlorothiazol-5-yl)methanol is used as a building block in the synthesis of various biologically active molecules for pharmaceutical drug development. Its unique chemical structure and properties make it a promising candidate for creating new drugs with potential therapeutic effects.
Used in Agrochemicals:
(4-chlorothiazol-5-yl)methanol may have applications in the development of agrochemicals, such as pesticides or herbicides, due to its chemical properties and potential for synthesis into active compounds.
Used in Material Science:
(4-chlorothiazol-5-yl)methanol could be utilized in material science for the development of new materials with specific properties, such as improved stability or reactivity, based on its chemical structure and potential for synthesis into various compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1025936-09-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,5,9,3 and 6 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1025936-09:
(9*1)+(8*0)+(7*2)+(6*5)+(5*9)+(4*3)+(3*6)+(2*0)+(1*9)=137
137 % 10 = 7
So 1025936-09-7 is a valid CAS Registry Number.
1025936-09-7Relevant articles and documents
HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS
-
Paragraph 000274, (2015/10/05)
ABSTRACT The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
